SCHEMBL8329920

SCHEMBL8329920

COc1cccc(Cc2cccc3[nH]nc(-c4ccc(CO)o4)c23)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.39
GPR55 Q9Y2T6 2/20 0.37
CNR1 P21554 1/20 0.37
FGFR1 P11362 1/20 0.37
FGFR4 P22455 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MAP2K4 P45985 1/20 0.36
DHFR P00374 1/20 0.36
HTR6 P50406 1/20 0.36
HTR1A P08908 1/20 0.36
DRD2 P14416 1/20 0.36
HTR2B P41595 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
HTR1B P28222 1/20 0.35
CNR2 P34972 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ATM Q13315 1/20 0.35
HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL163795 0.85 HIF1A (0.44) PDE5ASMN1; SMN2MAP2K4MEN1KMT2A
SCHEMBL8328669 0.85 MAP2K4 (0.43) PDE5ASMN1; SMN2MAP2K4HIF1AEPAS1
SCHEMBL8330242 0.80 MAP2K4 (0.39) PDE5ASMN1; SMN2FGFR1MAP2K4HTR6
SCHEMBL5971777 0.78 PDE5A (0.45) PDE5AMAP2K4HTR6MEN1KMT2A
SCHEMBL8332364 0.77 PDE5A (0.41) PDE5ASMN1; SMN2MAP2K4HIF1AEPAS1
SCHEMBL8470062 0.77 CYP1A2 (0.36) PDE5ASMN1; SMN2FGFR1NPSR1MAP2K4
SCHEMBL8330465 0.73 PDE5A (0.39) PDE5ASMN1; SMN2MAP2K4HIF1AEPAS1
SCHEMBL5493286 0.73 KDM4E (0.41) SMN1; SMN2NPSR1MEN1KMT2AHIF1A
SCHEMBL8470520 0.72 CYP1A2 (0.39) SMN1; SMN2FGFR1MAP2K4MEN1KMT2A
SCHEMBL8329288 0.72 PDE5A (0.40) PDE5ASMN1; SMN2MAP2K4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0932403-A1 USE OF CONDENSATED (HETARYL-SUBSTITUTED) 1-BENZAL-3-PYRAZOL DERIVATES FOR TREATING SPECIAL DISEASES OF THE CARDIOVASCULAR AND THE CENTRAL NERVOUS SYSTEMS BAYER AG (DE) 1999-08-04 EP claimed
WO-1998016223-A1 USE OF CONDENSATED (HETARYL-SUBSTITUTED) 1-BENZAL-3-PYRAZOL DERIVATES FOR TREATING SPECIAL DISEASES OF THE CARDIOVASCULAR AND THE CENTRAL NERVOUS SYSTEMS BAYER AKTIENGESELLSCHAFT (DE) 1998-04-23 WO claimed